Description
PT-141, also known as bremelanotide, is a synthetic peptide analogue associated with melanocortin-receptor research. The compound has been investigated in studies of receptor activity and neurobehavioural signalling. This 10mg entry identifies the research material without making a sexual-performance or treatment claim.
Mechanism & Research Background
Published research describes PT-141 as an agonist at melanocortin receptors, including MC3R and MC4R. Its scientific context therefore concerns melanocortin pathways rather than the phosphodiesterase-5 pathway associated with some other compounds studied in sexual-response research. Receptor activity, exposure and behavioural endpoints are separate measurements and should not be treated as interchangeable evidence.
Areas of Research
- Melanocortin receptor activation and comparative receptor pharmacology.
- Relationships between receptor signalling and experimental neurobehavioural endpoints.
- Compound identity and exposure-response measurements in defined study models.
Studies involving a pharmaceutical formulation of bremelanotide do not validate a supplier’s research batch or show equivalence to that formulation. The precise chemical identity, salt form and analytical results need to match the material under investigation. A catalogue strength is also different from an assay concentration.
Product Details
- Product: PT141 10mg
- Listed quantity: 10mg
- Compound class: Melanocortin receptor agonist peptide
- Product code: P41
Storage & Handling
Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.
Batch Documentation
Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.
Research References
Important Notice
Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.
Reviews
There are no reviews yet.